General Information of the Compound
| Compound ID |
CP0901747
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-2-(2-Aminothiazol-4-yl)-N-(4-(((2S,5R)-5-((R)-hydroxy-(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-3-methylbutanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H32N4O2S
|
||||||||||||||||||
| Molecular Weight |
464.635
|
||||||||||||||||||
| Canonical SMILES |
CC(C)[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H32N4O2S/c1-16(2)23(22-15-33-26(27)30-22)25(32)29-19-10-8-17(9-11-19)14-20-12-13-21(28-20)24(31)18-6-4-3-5-7-18/h3-11,15-16,20-21,23-24,28,31H,12-14H2,1-2H3,(H2,27,30)(H,29,32)/t20-,21+,23+,24+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CPVGCMLIKUWWGY-XWVZOOPGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor